JAK2 Gene Polycythemia Vera Somatic Genetic Test
At DNA Labs UAE, we offer the JAK2 Gene Polycythemia Vera Somatic Genetic Test for individuals suspected of having polycythemia vera. This test is designed to detect mutations in the JAK2 gene that are associated with this condition.
Test Components and Price
The JAK2 Gene Polycythemia Vera Somatic Genetic Test is priced at 4400.0 AED. The test components include:
- Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
- Report Delivery: 3 to 4 Weeks
- Method: NGS Technology
- Test Type: Cancer
- Doctor: Oncologist
- Test Department: Genetics
Pre Test Information
Prior to undergoing the JAK2 Gene Polycythemia Vera Somatic Genetic Test, it is important for the patient to provide their clinical history. Additionally, a genetic counseling session may be conducted to draw a pedigree chart of family members affected by JAK2 Gene Polycythemia Vera. This information will help in the interpretation of the test results.
Test Details
The JAK2 Gene Polycythemia Vera Somatic Genetic Test is a somatic NGS genetic test used to detect mutations in the JAK2 gene associated with polycythemia vera. Polycythemia vera is a type of blood cancer characterized by the overproduction of red blood cells. The JAK2 gene plays a crucial role in regulating blood cell production.
Mutations in the JAK2 gene can lead to the overactivation of the protein it produces, resulting in abnormal cell growth and division in the bone marrow. The somatic NGS genetic test analyzes a sample of DNA from the patient’s blood or bone marrow to identify specific mutations, such as the JAK2 V617F mutation, which is commonly found in patients with polycythemia vera.
This test serves multiple purposes, including confirming a diagnosis of polycythemia vera, distinguishing it from other conditions with similar symptoms, monitoring treatment response, and detecting disease recurrence. Overall, the JAK2 Gene Polycythemia Vera Somatic Genetic Test is a valuable tool for the diagnosis and management of this condition.
| Test Name | JAK2 Gene Polycythemia vera somatic Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Cancer |
| Doctor | Oncologist |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for JAK2 Gene Polycythemia vera, somatic NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with JAK2 Gene Polycythemia vera, somatic NGS Genetic DNA Test gene JAK2 |
| Test Details | A somatic NGS genetic test for the JAK2 gene is used to detect mutations in the JAK2 gene that are associated with a condition called polycythemia vera. Polycythemia vera is a type of blood cancer characterized by the overproduction of red blood cells. The JAK2 gene provides instructions for making a protein that is involved in regulating the production of blood cells. Mutations in the JAK2 gene can lead to the overactivation of this protein, causing abnormal cell growth and division in the bone marrow. A somatic NGS genetic test analyzes a sample of DNA from a patient’s blood or bone marrow to detect specific mutations in the JAK2 gene. This test can identify mutations such as the JAK2 V617F mutation, which is found in a majority of patients with polycythemia vera. By detecting these mutations, the test can help confirm a diagnosis of polycythemia vera and differentiate it from other conditions with similar symptoms. It can also be used to monitor the response to treatment and detect any recurrence of the disease. Overall, a somatic NGS genetic test for the JAK2 gene in polycythemia vera is an important tool for diagnosing and managing this condition. |
